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A B S T R A C T
The purpose of this investigation was to determine the role of alcohol in development
of progressive liver disease. For this purpose, 41 alcoholic patients were followed up for
5 years. Criteria for alcohol abuse was that the patients were enjoying 20 g alcohol daily
in a period of 5 years for females and respectively 60 g daily for males. In the same time
a group of 51 nonalcoholic patients with histologically proven chronic liver disease were
investigated. In all 92 patients chronic liver disease and progression of the disease was
proven by liver biopsy during a 5-years follow-up. In sera of all patients the markers of
hepatitis viruses B, D and C were continuously determined and chronic viral hepatitis
was excluded. Also, autoimmune chronic hepatitis was excluded. The results of the in-
vestigation showed that alcoholics develop cirrhosis hepatitis, in most cases 78.04%.
The most progressive chronic liver diseases – cirrhosis and hepatocellular carcinoma –
are significantly present among nonalcoholics (p  0.05). In the mentioned investigation
a large group of 51 patients with severe chronic hepatitis without a proven ethiology of
disease was found and it deserves priority in future research.
Introduction
Although in the past few decades hun-
dreds of scientists have been concerned
with chronic viral hepatitis, alcohol as a
cause of liver disease remains the most
frequent ethiologic factor. In spite of long-
years researches, the role of alcohol in de-
velopment of chronic liver diseases is not
entirely clear; present are also genetic
factors, gender, quantity and duration of
alcohol abuse, immunological events in
the liver. We are still surprised by the
uncleared fact that only 15% to 20% of al-
coholics develop liver disease and that fe-
male population is more sensitive to alco-
hol consumption. Since we follow up
many patients with chronic liver diseases
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of different causes, we wanted to deter-
mine the role of alcohol in development of
progressive liver chronic diseases1–3.
Patients and Methods
In a group of 41 patients with the his-
tory of alcohol abuse and with histolo-
gically proven chronic liver disease, we
checked anamnestic data of the patients
who were continuously taking alcohol af-
ter a period of 48 months. Criteria for al-
cohol abuse was that the patients were
enjoying 20 g alcohol daily in a period of 5
years for females and 60 g daily for ma-
les. In the same time, we investigated a
group of 51 patients with histologically
proven chronic liver disease, but without
history of alcohol abuse. In that whole
group of 92 patients, at the moment of the
first liver biopsy, we excluded the infec-
tion by B, D and C hepatitis virus in their
sera.
After 48 months we performed a con-
trol liver biopsy. After that, we followed
the whole group during 12 months and
every four months during clinical control
we determined HBV markers in their
sera. Testing of the sera markers HbsAg,
anti- HBs, anti-HBC, HbeAg, anti-Hbe,
was performed by the commercial meth-
ods RIA and EIA (BEAD test) Abbot Lab-
oratories, North Chicago, Illinois, USA.
HBV-DNA-PCR was performed by the
Roche-Amplicor test. Anti-HCV Elisa test
by the Ortho Clinical Diagnostic, Rha-
ritan, USA was used. Anti-Hd was tested
by the RIA Abbot commercial test. In the
sera of our patients we also determined
ANA (anti-nuclear) and SMA (anti-
smooth muscle antibodies) by immuno-
florescence. Histological diagnosis was
made according to the accepted classifica-
tion of CPH (chronic persistent hepati-
tis), CAH (chronic active hepatitis), CH
(cirrhosis hepatis), HCC (hepatocellular
carcinoma), N (normal finding)4–6. The
history of previous acute and blood trans-
fusion was taken. Hemochromatosis and
Wilson disease were excluded in all pa-
tients. All the patients with cirrhosis he-
patis at the beginning of the investiga-
tion had Child Pugh A degree. All results
were statistically computed: a test of sig-
nificance X with the Yates correction for
small numbers was used. X was signifi-
cant if higher than 3.841, p  0.05. As
well the 95% interval of confidence was
used for results expressed in percentage.
The numbers in brackets mean upper
and lower limits of the 95 % interval of
confidence.
Results
In 92 patients, 59 male and 33 female,
chronic liver disease was histologically
proven. Among 41 of them, 44.56% (29–
62%) were alcoholics and 78.04% (60–
91%) of these alcoholics had cirrhosis he-
patis. In 51 patients who were not alco-
holics 33.3% (12–61%) had CH and 21.6%
(3–57%) had CAH.
After 48 months we performed 17 con-
trol biopsies. 7 patients with CAH devel-
oped CH in the group of nonalcoholics.
Among alcoholics 5 patients with CPH
developed CH and 2 developed CAH. In
the same group 3 patients with previous
normal findings developed CPH and 2 de-
veloped CAH. All 92 patients were sero-
logically negative for markers of B, C and
D hepatitis virus during a period of the
next 12 months. ANA and SMA were pos-
itive in 27.17% (11–47%) patients.
However, no one among the patients
had criteria for autoimmune liver disease
and there was no statistical difference of
ANA and SMA between alcoholics and
nonalcoholics8. After 12 months of sero-
logical and clinical follow-up in 13 pa-
tients a control biopsy was performed.
Two patients with CAH and one with CH
developed HCC in the group of nonal-
coholics. Among alcoholics one patient
with CH had a regression into CAH and 9
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patients with CH again had the same dis-
ease.
After 5 years of follow-up 6 (52%) pa-
tients died: three nonalcoholics with de-
veloped HCC and three alcoholics with
CH. Although the alcoholics had very se-
vere hepatic disease, there was a signifi-
cant statistical difference in relation to
nonalcoholics (X2 = 8.4212, p  0.05).
Because of such unexpected result we
compared this group of patients with the
patients with HBV chronic hepatitis.
There was a significant difference be-
tween severe chronic hepatitis of alcohol-
ics without markers of HBV and chronic
hepatitis in nonalcoholics, but HBsAg po-
sitive (X2 = 8.2407, p  0.05). However,
the patients with chronic HBV hepatitis
and with markers for viral replication
had significant difference in relation to
alcoholics without HBV markers (X2 =
4.0502 p  0.05). It means that our non-
alcoholic patients without markers for vi-
ral hepatitis viruses developed the most
progressive forms of liver disease.
Discussion
The mechanism of development of
chronic liver disease among alcoholics is
multifactorial9. In one of our previous in-
vestigations out of 401 patients with his-
tologically proven chronic liver disease
48.9% (41–54%) were alcoholics. Among
196 alcoholics 44.4% (33–56%) were neg-
ative for serological markers of HB virus.
In this group 25.4% (16–33%)10 had CH.
Alcoholic cirrhosis is a very severe chro-
nic hepatitis with a bad prognosis.
In a prospective study of 270 cirrhotics
more than a half died within 48 months
and 1/3 of these patients had a combina-
tion with alcohol hepatitis11. The results
of our investigation demonstrate that the
majority of our alcoholic patients have
CH, but after a 5-year follow-up the mor-
tality was not so high. Nevertheless, alco-
hol abuse in our patients causes signifi-
cantly more severe chronic hepatitis
compared to the patients with chronic
HBV nonalcoholic hepatitis.
Alcohol abstinence is the only attenu-
ating factor since the five-year survival of
cirrhotics who continue drinking is 50%.
According to that fact, therapy against al-
cohol abuse could have an effect to the re-
duction of alcoholic liver disease. Liver
transplantation among alcoholics is also
questionable because it is recommended
for abstinent patients and the relaps of
disease in transplant patients who con-
tinue to drink is more often12,13.
It is well known that in spite of the use
of many diagnostic methods, 10% of pa-
tients have severe chronic liver disease
with significant progression, still without
a proven ethiology of disease. Mortality
among such patients is increased in 75%
of the cases. Our results correspond to
such investigations because they show
that our nonalcoholic patients without
any viral infection have significant severe
chronic hepatitis. Among them, after a
5-year follow up, hepatocellular carcino-
ma developed14–18.
In conclusion, alcoholism is one of the
most important causes of chronic liver
disease in our patients and has to be re-
solved together with all other aspects.
Along with that, the patients with severe
chronic hepatitis, but of unknown ethio-
logy, have priority in our future research.
Through this investigation we perceived
that keeping up with up-to-date knowl-
edge on liver diseases we are very often
occupied by the problems which are not
decisive in our national pathology. There-
fore, we have to check exactly every indi-
vidual patient with chronic liver disease
in order to give him/her optimal treat-
ment.
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PROGNOZA U ALKOHOLNOJ I NEALKOHOLNOJ KRONI^NOJ
BOLESTI JETRE
S A @ E T A K
Cilj ispitivanja bio je utvrditi utjecaj alkohola na razvoj kroni~ne bolesti jetre. U tu
svrhu pra}en je tijekom 5 godina 41 bolesnik s utvr|enim alkoholizmom. Alkoholizam
je utvr|en anamnesti~kim podatkom o konzumaciji etila 20 g dnevno kroz 5 godina za
`ene, te 60 g dnevno kroz 5 godina za mu{karce. Istodobno je pra}ena grupa od 51
nealkoholi~ara s kroni~nim hepatitisima. U svih 92 bolesnika bolest jetre je utvr|ena
histolo{kom verifikacijom, a progresija bolesti dokazana je tako|er biopti~ki tijekom
petogodi{njeg pra}enja. U svih 92 bolesnika kontinuirano su u serumu odre|ivani bi-
ljezi hepatitis virusa B, D i C, kao i ANA i AMA, te je u svih isklju~ena virusna kro-
ni~na bolest jetre ili autoimuni hepatitis. Rezultati ispitivanja pokazali su da u alko-
holi~ara prevladava ciroza jetre u 78,04 % slu~ajeva, ali da su te{ki oblici kroni~nog
hepatitisa, odnosno ciroza i karcinom jetre statisti~ki zna~ajno prisutni u nealkoho-
li~ara (p  0,05). Navedenim ispitivanjem izna|ena je velika grupa od 51 bolesnika s
progresivnim oboljenjima jetre kojima nije utvr|ena etiologija oboljenja ~ime je pos-
tavljen ozbiljan zadatak istra`ivanja uzro~nika njihove bolesti.
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